FIREFLY NEUROSCIENCE, INC.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: March 31, 2026 | Firefly Neuroscience, Inc. |
|---|---|
| /s/ Greg Lipschitz | |
| Name: Greg Lipschitz | |
| Title: Chief Executive Officer | |
| (Principal Executive Officer) | |
| /s/ Paul Krzywicki | |
| Name: Paul Krzywicki | |
| Title: Chief Financial Officer | |
| (Principal Financial and Accounting Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Greg Lipschitz | Chief Executive Officer (principal executive officer) and Director | March 31, 2026 |
| Greg Lipschitz | ||
| /s/ Paul Krzywicki | Chief Financial Officer (principal financial officer and principal accounting officer) | March 31, 2026 |
| Paul Krzywicki | ||
| /s/ David DeCaprio | President, Chief Operating Officer, and Director | March 31, 2026 |
| David DeCaprio | ||
| /s/ Arun Menawat | Chairman of the Board of Directors | March 31, 2026 |
| Arun Menawat | ||
| /s/ Brian Posner | Director | March 31, 2026 |
| Brian Posner | ||
| /s/ Stella Vnook | Director | March 31, 2026 |
| Stella Vnook | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.